ACO Participants

  • Brackenrich Family Practice PLC
  • Casey Health Institute Inc
  • Dunkirk Family Practice PA
  • Green Spring Internal Medicine, LLC
  • Jesse Sadikman, MD, LLC
  • Western Maryland Health Care Corporation
  • WVVA Health Care Alliance PC

No participants are involved in a joint venture between ACO professionals and hospitals

ACO Governing Body

  • Dahlman, Holly, Physician, 1, Voting Member, ACO Participant Representative, Green Spring Internal Medicine, LLC
  • Long, Shawn, Physician, 1, Voting Member, ACO Participant Representative, Western Maryland Health Care Corporation
  • Sadikman, Jesse, Physician, 1, Voting Member, ACO Participant Representative, Jesse Sadikman, MD, LLC
  • Fogel, David, Physician, 1, Voting Member, ACO Participant Representative, Casey Health Institute Inc
  • Goff, Amy, Physician, 1, Voting Member, ACO Participant Representative, WVVA Health Care Alliance PC
  • Brackenrich, Nadine, 1, Voting Member, ACO Participant Representative, Brackenrich Family Practice PLC
  • Owens, Joyce, Physician, 1, Voting Member, ACO Participant Representative, Dunkirk Family Practice PA
  • Bowles, Dan, 1, Chair and Voting Member, Aledade, Inc., N/A

Key Clinical and Administrative Leadership

  • Executive Director: Mr. Dan Bowles
  • Medical Director: Dr. Jesse Sadikman
  • Compliance Officer: Mr. Brian Lynch
  • Quality Assurance/Improvement Officer: Dr. Emily Maxson

ACO Committees and Committee Leaderships

  • Beneficiary Engagement Committee: Dr. David Krasner, Chair
  • Compliance Committee: Dr. Sal Volpe, Chair
  • Transitions of Care Committee: Dr. Rebecca Jaffe, Chair
  • Evidence-Based Medicine Committee: Dr. Charles Stanislav, Co-Chair and Dr. Holly Dahlman, Co-Chair
  • Performance Improvement Committee: Dr. Sarah Mullins, Co-Chair and Dr. Beshara Helou, Co-Chair

Composition of ACO

  • A network of individual practices of ACO professionals

Amount of Shared Savings/Losses

  • Agreement period beginning 2015: Performance Year 2015: $0
  • Agreement period beginning 2015: Performance Year 2016, $0

How Shared Savings Are Distributed

Agreement period beginning 2015, Performance Year 2015

Agreement period beginning 2015, Performance Year 2016

10%

Reinvest in infrastructure

30%

Invested in redesigned care processes/resources

60%

Distribution to ACO Participants

100%

Primary Care Professionals

N/A

Specialists

N/A

Hospital

Payment Rule Waivers

  • No, our ACO does not utilize the SNF 3-Day Rule Waiver

Quality Reporting

ACO#Measure NameRateACO Mean
Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.
ACO-1CAHPS: Getting Timely Care, Appointments, and Information 81.3880.51
ACO-2CAHPS: How Well Your Providers Communicate 93.5493.01
ACO-3CAHPS: Patients’ Rating of Provider 92.3592.25
ACO-4CAHPS: Access to Specialists 83.0983.49
ACO-5CAHPS: Health Promotion and Education56.8860.32
ACO-6CAHPS: Shared Decision Making 72.7875.4
ACO-7CAHPS: Health Status/Functional Status 71.7572.3
ACO-34CAHPS: Stewardship of Patient Resources 24.6426.97
ACO-8Risk Standardized, All Condition Readmission14.7714.7
ACO-35Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)18.6818.17
ACO-36All-Cause Unplanned Admissions for Patients with Diabetes50.753.2
ACO-37All-Cause Unplanned Admissions for Patients with Heart Failure68.2975.23
ACO-38All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions53.259.81
ACO-9Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)9.049.27
ACO-10Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8)14.4714.53
ACO-11Percent of PCPs who Successfully Meet Meaningful Use Requirements10082.72
ACO-39Documentation of Current Medications in the Medical Record98.3587.54
ACO-13Falls: Screening for Future Fall Risk 5064.04
ACO-14Preventive Care and Screening: Influenza Immunization74.4468.32
ACO-15Pneumonia Vaccination Status for Older Adults72.0869.21
ACO-16Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up76.6674.45
ACO-17Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention93.1290.98
ACO-18Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan45.8653.63
ACO-19Colorectal Cancer Screening66.4361.52
ACO-20Breast Cancer Screening70.5767.61
ACO-21Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented 74.0476.79
ACO-42Statin therapy for the Prevention and Treatment of Cardiovascular Disease85.9477.72
ACO-27Diabetes Mellitus: Hemoglobin A1c Poor Control 15.2218.24
ACO-41Diabetes: Eye Exam49.2544.94
ACO-28Hypertension (HTN): Controlling High Blood Pressure 71.0470.69
ACO-30Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic88.6285.05
ACO-31Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)94.6788.67
ACO-33Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)88.5279.67

For 2016 Quality Performance Results please visit: https://data.cms.gov/Special-Programs-Initiatives-Medicare-Shared-Savin/2016-Shared-Savings-Program-SSP-Accountable-Care-O/3jk5-q6dr/data
For 2015 Quality Performance Results please visit: https://data.cms.gov/Special-Programs-Initiatives-Medicare-Shared-Savin/Medicare-Shared-Savings-Program-Accountable-Care-O/x8va-z7cu/data

Note: In the Quality Performance Results file(s) above, search for “Aledade Primary Care ACO LLC” to view the quality performance results. This ACO can also be found by using the ACO ID A87299 in the public use files on data.cms.gov.